Bristol Myers Squibb CEO says America’s edge in new drugs is ‘not a birthright’ as the U.S. loses its measles elimination status
On the day the U.S. lost its measles-elimination status, BMS CEO Chris Boerner warned against “policies that don’t” protect the drug ecosystem.
Fortune ·